Microbiome identification and bacteriophage formulations
US-2024123002-A1 · Apr 18, 2024 · US
Ehrlichia canis DIVA (differentiate infected from vaccinated animals)
US8980274B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8980274-B2 |
| Application number | US-201113010925-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 21, 2011 |
| Priority date | Oct 31, 2007 |
| Publication date | Mar 17, 2015 |
| Grant date | Mar 17, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention provides Ehrlichia canis antigens that can be used to detect E. canis infected animals regardless of whether the animals have been vaccinated for E. canis . The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.
First claim
Opening claim text (preview).
We claim 1. A composition comprising: (A) one or more purified polypeptides consisting of SEQ ID NO:22-33; (B) one or more purified polypeptides having at least 95% identity to 15 to 27 contiguous amino acids of SEQ ID NO:22; 15 to 30 contiguous amino acids of SEQ ID NO:23; 15 to 27 contiguous amino acids of SEQ ID NO:24; 15 to 27 contiguous amino acids of SEQ ID NO:25; 15 to 30 contiguous amino acids of SEQ ID NO:26; 15 to 27 contiguous amino acids of SEQ ID NO:27;…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- G01N33/56911Primary
Physics · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8980274B2 cover?
- The invention provides Ehrlichia canis antigens that can be used to detect E. canis infected animals regardless of whether the animals have been vaccinated for E. canis . The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.
- Who is the assignee on this patent?
- Krah Iii Eugene Regis, Beall Melissa, O'Connor Jr Thomas Patrick, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification G01N33/56911. Mapped technology areas include Physics.
- When was this patent published?
- Publication date Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).